Delivery Order SPE2DB20D3103-SPE2DB25FL4P5

Award Date 10/22/24
Potential Completion Date 10/23/24
Potential Value $3.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of DEXCOM G7 SENSORS to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $1,365.48 firm fixed-price delivery order was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of February 19, 2025 and was awarded on February 18, 2025. The contract is not designated with a set-aside....
This federal contract award was granted by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,295.76 firm fixed-price delivery order is for the provision of Dexcom G7 Sensors, a medical device used for glucose monitoring. The contract has an ultimate completion date of November 26, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, with a value of $7,884.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dexcom G7 sensors, a type of continuous glucose monitoring device used in the management of diabetes. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and...
This federal contract award is for the delivery of DEXCOM G7 SENSORS to the Defense Logistics Agency (DLA). The $1,255.76 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a child contract under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This federal contract award is for the delivery of DEXCOM G7 SENSORS to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $6,870.36, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the Ultimate Completion Date is March 14, 2025. The contract is not designated with a set-aside requirement,...
This federal contract award is for the delivery of DEXCOM G7 SENSORS to the Defense Logistics Agency (DLA). The $4,821.44 firm-fixed-price delivery order contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of October 24, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical for...
This federal contract award, valued at $1,086.87, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dexcom G7 sensors, a medical device for diabetes management. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award is for the supply of DEXCOM G7 SENSORS, a medical device product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $1,708.46 and an ultimate completion date of January 29, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of DEXCOM G7 SENSORS to the Defense Logistics Agency (DLA). The $4,845.89 firm fixed-price delivery order has a completion date of December 12, 2024. The contract is not associated with a set-aside program. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award is for the delivery of DEXCOM G7 SENSORS to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $4,259.11, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FL4P5
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp (ABDC), a major pharmaceutical distributor, provides Dexcom G7 glucose sensors to the Defense Logistics Agency (DLA). The $3,246.86 firm-fixed-price delivery order, with an ultimate completion date of October 23, 2024, is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between ABDC and the DLA Troop Support Medical. This IDC serves as a primary vehicle for ABDC to supply a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, and test kits, to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. In addition to the DLA contract, ABDC also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 2/27/25, 9:45 AM